Zdrowie i gospodarka · 14/03/2019
FDA Requests Public Comment on Proposed Regulations for Positron Emission Tomography Drugs
The Food and Drug Administration is seeking public input on its proposed regulations for current good manufacturing practices for positron emission tomography drugs, as required by the Paperwork Reduction Act of 1995.